Grade A and B Flashcards

1
Q

Abdominal aortic aneurysm screening: men

A

Grade B

The USPSTF recommends one-time screening for abdominal aortic aneurysm by ultrasonography in men ages 65 to 75 years who have ever smoked. June 2014*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Aspirin preventive medication: adults aged 50 to 59 years

A

Grade B

Aspirin preventive medication: 
adults aged 50 to 59 years with 
≥10% 10-year cardiovascular risk	
10 year life expectancy at least
willing to take it daily for 10 years
and no risk of bleeding

The USPSTF recommends initiating low-dose aspirin use for the primary prevention of cardiovascular disease and colorectal cancer in adults aged 50 to 59 years who have a 10% or greater 10-year cardiovascular risk, are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take low-dose aspirin daily for at least 10 years. April 2016*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Bacteriuria screening: pregnant women

A

Grade B

Bacteriuria screening: pregnant women The USPSTF recommends screening for asymptomatic bacteriuria using urine culture in pregnant persons. B September 2019*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Blood pressure screening: adults

A

Grade A

Blood pressure screening: adults The USPSTF recommends screening for high blood pressure in adults aged 18 years or older. The USPSTF recommends obtaining measurements outside of the clinical setting for diagnostic confirmation before starting treatment. A October 2015*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

BRCA risk assessment and genetic counseling/testing

A

Grade B

The USPSTF recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk assessment tool. Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Breast cancer preventive medications

A

Grade B

The USPSTF recommends that clinicians offer to prescribe risk-reducing medications, such as tamoxifen, raloxifene, or aromatase inhibitors, to women who are at increased risk for breast cancer and at low risk for adverse medication effects. September 2019*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Breast cancer screening

A

Grade B

USPSTF recommends screening mammography for women, with or without clinical breast examination, every 1 to 2 years for women age 40 years and older.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Breastfeeding interventions

A

Grade B

Breastfeeding interventions The USPSTF recommends providing interventions during pregnancy and after birth to support breastfeeding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cervical cancer screening

A

Grade A

The USPSTF recommends screening for cervical cancer

women aged 21-29: every 3 years with cervical cytology alone

women aged 30-65: every 3 years with cervical cytology alone + every 5 years with hrHPV testing alone OR every 5 years with hrHPV + cervical cytology combo

the USPSTF recommends screening every 3 years with cervical cytology alone, every 5 years with high-risk human papillomavirus (hrHPV) testing alone, or every 5 years with hrHPV testing in combination with cytology (cotesting).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chlamydia screening: women

A

Grade B

Chlamydia screening: women

The USPSTF recommends screening for chlamydia in sexually active women age 24 years or younger and in older women who are at increased risk for infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Colorectal cancer screening

A

Grade A

The USPSTF recommends screening for colorectal cancer starting at age 50 years and continuing until age 75 years.
June 2016*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dental caries prevention: infants and children up to age 5 years

A

Grade B

The USPSTF recommends the application of fluoride varnish to the primary teeth of all infants and children starting at the age of primary tooth eruption in primary care practices. The USPSTF recommends primary care clinicians prescribe oral fluoride supplementation starting at age 6 months for children whose water supply is fluoride deficient. B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Depression screening: adolescents

A

Grade B

The USPSTF recommends screening for major depressive disorder (MDD) in adolescents aged 12 to 18 years. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Depression screening: adults

A

Grade B

USPSTF recommends screening for depression in the general adult population, including pregnant and postpartum women. Screening should be implemented with adequate systems in place to ensure accurate diagnosis, effective treatment, and appropriate follow-up.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Diabetes screening

A

Grade B

The USPSTF recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in adults aged 40 to 70 years who are overweight or obese. Clinicians should offer or refer patients with abnormal blood glucose to intensive behavioral counseling interventions to promote a healthful diet and physical activity. B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Falls prevention: older adults

A

Grade B

The USPSTF recommends exercise interventions to prevent falls in community-dwelling adults 65 years or older who are at increased risk for falls.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Folic acid supplementation

A

Grade A

The USPSTF recommends that all women who are planning or capable of pregnancy take a daily supplement containing 0.4 to 0.8 mg (400 to 800 µg) of folic acid. A January 2017*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Gestational diabetes mellitus screening

A

Grade B

Gestational diabetes mellitus screening The USPSTF recommends screening for gestational diabetes mellitus in asymptomatic pregnant women after 24 weeks of gestation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Gonorrhea prophylactic medication: newborns

A

Grade A

Gonorrhea prophylactic medication: newborns The USPSTF recommends prophylactic ocular topical medication for all newborns to prevent gonococcal ophthalmia neonatorum. A January 2019*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Gonorrhea screening: women

A

Grade B

The USPSTF recommends screening for gonorrhea in sexually active women age 24 years or younger and in older women who are at increased risk for infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Healthy diet and physical activity counseling to prevent cardiovascular disease: adults with cardiovascular risk factors

A

Grade B

Healthy diet and physical activity counseling to prevent cardiovascular disease: adults with cardiovascular risk factors The USPSTF recommends offering or referring adults who are overweight or obese and have additional cardiovascular disease (CVD) risk factors to intensive behavioral counseling interventions to promote a healthful diet and physical activity for CVD prevention.

22
Q

Hemoglobinopathies screening: newborns

A

Grade A

Hemoglobinopathies screening: newborns The USPSTF recommends screening for sickle cell disease in newborns. A September 2007

23
Q

Hepatitis B screening: nonpregnant adolescents and adults

A

Grade B

The USPSTF recommends screening for hepatitis B virus infection in persons at high risk for infection.

24
Q

Hepatitis B screening: pregnant women

A

Grade A

The USPSTF recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit
July 2019*

25
Q

Hepatitis C virus infection screening: adults

A

Grade B

The USPSTF recommends screening for hepatitis C virus (HCV) infection in persons at high risk for infection. The USPSTF also recommends offering one-time screening for HCV infection to adults born between 1945 and 1965.
26
Q

HIV preexposure prophylaxis for the prevention of HIV infection

A

Grade A

The USPSTF recommends that clinicians offer preexposure prophylaxis (PrEP) with effective antiretroviral therapy to persons who are at high risk of HIV acquisition.
27
Q

HIV screening: adolescents and adults ages 15 to 65 years

A

Grade A

The USPSTF recommends that clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years. Younger adolescents and older adults who are at increased risk of infection should also be screened.

28
Q

HIV screening: pregnant women

A

Grade A

The USPSTF recommends that clinicians screen for HIV infection in all pregnant persons, including those who present in labor or at delivery whose HIV status is unknown.
29
Q

Hypothyroidism screening: newborns

A

Grade A

The USPSTF recommends screening for congenital hypothyroidism in newborns.

30
Q

Intimate partner violence screening: women of reproductive age

A

Grade B

The USPSTF recommends that clinicians screen for intimate partner violence in women of reproductive age and provide or refer women who screen positive to ongoing support services. B October 2018

31
Q

Lung cancer screening

A

The USPSTF recommends annual screening for lung cancer with low-dose computed tomography in adults ages 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery. B December 2013

32
Q

Obesity screening and counseling: adults

A

Grade B

The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher (calculated as weight in kilograms divided by height in meters squared) to intensive, multicomponent behavioral interventions.

33
Q

Obesity screening: children and adolescents

A

Grade B

Obesity screening: children and adolescents The USPSTF recommends that clinicians screen for obesity in children and adolescents 6 years and older and offer or refer them to comprehensive, intensive behavioral interventions to promote improvements in weight status.

34
Q

Osteoporosis screening: postmenopausal women younger than 65 years at increased risk of osteoporosis

A

Grade B

The USPSTF recommends screening for osteoporosis with bone measurement testing to prevent osteoporotic fractures in postmenopausal women younger than 65 years who are at increased risk of osteoporosis, as determined by a formal clinical risk assessment tool. B June 2018

35
Q

Osteoporosis screening: women 65 years and older

A

Grade B

The USPSTF recommends screening for osteoporosis with bone measurement testing to prevent osteoporotic fractures in women 65 years and older. B June 2018*

36
Q

Perinatal depression: counseling and interventions

A

Grade B

Perinatal depression: counseling and interventions The USPSTF recommends that clinicians provide or refer pregnant and postpartum persons who are at increased risk of perinatal depression to counseling interventions. B February 2019
Phenylketonuria screening: newborns The USPSTF recommends screening for phenylketonuria in newborns. B March 2008

37
Q

Phenylketonuria screening: newborns

A

Phenylketonuria screening: newborns The USPSTF recommends screening for phenylketonuria in newborns. B March 2008

38
Q

Preeclampsia prevention: aspirin

A

Grade B

Preeclampsia prevention: aspirin The USPSTF recommends the use of low-dose aspirin (81 mg/d) as preventive medication after 12 weeks of gestation in women who are at high risk for preeclampsia. B September 2014

39
Q

Preeclampsia: screening

A

Grade B

Preeclampsia: screening The USPSTF recommends screening for preeclampsia in pregnant women with blood pressure measurements throughout pregnancy. B April 2017

40
Q

Rh incompatibility screening: first pregnancy visit

A

Grade A

The USPSTF strongly recommends Rh (D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care.

41
Q

Rh incompatibility screening: 24–28 weeks’ gestation

A

Grade B

The USPSTF recommends repeated Rh (D) antibody testing for all unsensitized Rh (D)-negative women at 24 to 28 weeks’ gestation, unless the biological father is known to be Rh (D)-negative.

42
Q

Sexually transmitted infections counseling

A

Grade B

The USPSTF recommends intensive behavioral counseling for all sexually active adolescents and for adults who are at increased risk for sexually transmitted infections. B September 2014*

43
Q

Skin cancer behavioral counseling

A

Grade B

Skin cancer behavioral counseling The USPSTF recommends counseling young adults, adolescents, children, and parents of young children about minimizing exposure to ultraviolet (UV) radiation for persons aged 6 months to 24 years with fair skin types to reduce their risk of skin cancer. B March 2018*

44
Q

Statin preventive medication: adults ages 40–75 years with no history of CVD, 1 or more CVD risk factors, and a calculated 10-year CVD event risk of 10% or greater

A

Grade B

USPSTF recommends that adults without a history of cardiovascular disease (CVD) (i.e., symptomatic coronary artery disease or ischemic stroke) use a low- to moderate-dose statin for the prevention of CVD events and mortality when all of the following criteria are met:

1) they are ages 40 to 75 years;
2) they have 1 or more CVD risk factors (i.e., dyslipidemia, diabetes, hypertension, or smoking); and
3) they have a calculated 10-year risk of a cardiovascular event of 10% or greater. Identification of dyslipidemia and calculation of 10-year CVD event risk requires universal lipids screening in adults ages 40 to 75 years. B November 2016*

45
Q

Syphilis screening: nonpregnant persons

A

Grade A

The USPSTF recommends screening for syphilis infection in persons who are at increased risk for infection.

46
Q

Syphilis screening: pregnant women

A

Grade A

Syphilis screening: pregnant women The USPSTF recommends early screening for syphilis infection in all pregnant women. A September 2018*

47
Q

Tobacco use counseling and interventions: nonpregnant adults

A

Grade A

USPSTF recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and U.S. Food and Drug Administration (FDA)–approved pharmacotherapy for cessation to adults who use tobacco. A September 2015*
September 2015*

48
Q

Tobacco use counseling: pregnant women

A

Grade A

The USPSTF recommends that clinicians ask all pregnant women about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant women who use tobacco. A

49
Q

Tobacco use interventions: children and adolescents

A

Grade B

Tobacco use interventions: children and adolescents The USPSTF recommends that clinicians provide interventions, including education or brief counseling, to prevent initiation of tobacco use in school-aged children and adolescents. B August 2013

50
Q

Tuberculosis screening: adults

A

Grade B

USPSTF recommends screening for latent tuberculosis infection in populations at increased risk. B September 2016

51
Q

Unhealthy alcohol use: adults

A

Grade B

The USPSTF recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women, and providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use. B November 2018*

52
Q

Vision screening: children

A

Grade B

The USPSTF recommends vision screening at least once in all children ages 3 to 5 years to detect amblyopia or its risk factors. B September 2017